STOCK TITAN

[Form 4] NewGenIvf Group Ltd Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

HRT FINANCIAL LP, a ten percent owner of NewGenIvf Group Ltd, reported an open-market sale of Common Stock. On June 4, 2026, it sold 64,945 shares at $0.781 per share. After this transaction, HRT FINANCIAL LP directly holds 18,134 shares of NewGenIvf common stock.

Positive

  • None.

Negative

  • None.
Insider HRT FINANCIAL LP
Role null
Sold 64,945 shs ($51K)
Type Security Shares Price Value
Sale Common Stock 64,945 $0.781 $51K
Holdings After Transaction: Common Stock — 18,134 shares (Direct, null)
Footnotes (1)
Shares sold 64,945 shares Common Stock sold on June 4, 2026
Sale price $0.781 per share Price for NewGenIvf common stock sale
Shares after sale 18,134 shares Direct holdings after June 4, 2026 transaction
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
ten percent owner financial
"HRT FINANCIAL LP is marked as a ten percent owner"
Common Stock financial
"security_title is listed as Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HRT FINANCIAL LP

(Last)(First)(Middle)
3 WORLD TRADE CENTER, 175 GREENWICH STRE
76TH FLOOR

(Street)
NEW YORK NEW YORK 10007

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/04/2026S64,945D$0.78118,134D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Adam Nunes06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HRT FINANCIAL LP report for NewGenIvf (NIVF)?

HRT FINANCIAL LP reported selling 64,945 shares of NewGenIvf common stock in an open-market transaction on June 4, 2026, at $0.781 per share. This reduced its directly held position but did not eliminate its ownership.

At what price did HRT FINANCIAL LP sell NewGenIvf (NIVF) shares?

The shares were sold at $0.781 per share. This price applies to the 64,945 NewGenIvf common shares involved in the June 4, 2026 open-market sale reported in the insider filing.

How many NewGenIvf (NIVF) shares does HRT FINANCIAL LP hold after the sale?

After the reported sale, HRT FINANCIAL LP holds 18,134 shares of NewGenIvf common stock directly. This figure comes from the post-transaction ownership line in the Form 4 filing.

Is HRT FINANCIAL LP a major shareholder of NewGenIvf (NIVF)?

HRT FINANCIAL LP is identified as a ten percent owner of NewGenIvf. This designation means it beneficially owns at least ten percent of the company’s registered class of equity securities, based on the insider filing.

Was the NewGenIvf (NIVF) trade by HRT FINANCIAL LP an open-market sale?

Yes. The Form 4 classifies the transaction as an open-market sale of common stock. The sale code “S” and the description confirm it was executed in the open market or a similar private transaction.